Corticosteroid Therapy in COVID-19 Disease

被引:0
|
作者
Akbudak, Ismail Hakki [1 ]
机构
[1] Pamukkale Univ, Dept Internal Med, Div Intens Care Med, Fac Med, Denizli, Turkey
来源
关键词
Septic Shock; Coronavirus Infections; Respiratory Failure; Corticosteroids;
D O I
10.37678/dcybd.2020.2349
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Corticosteroid therapy has been used for many years and is still controversial in use. In the Coronovirus disease 2019 (COVID-19) outbreak, it is very important to find reliable treatment information for clinicians and patients. Low dose corticosteroids are also used in patients with septic shock, relative adrenal insufficiency and acute respiratory distress syndrome (ARDS). There is not enough evidence for its use in COVID-19. However, low dose use is recommended in the case of ARDS and septic shock in COVID-19 patients. Caution should be exercised until further evidence emerges surrounding the use of corticosteroids in COVID-19 patients.
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [41] Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
    Perez-Belmonte, Luis M.
    Sanz-Canovas, Jaime
    Salinas, Alejandro
    Fornie, Inigo Sagastagoitia
    Mendez-Bailon, Manuel
    Gomez-Huelgas, Ricardo
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (08) : 2301 - 2305
  • [42] PRCTC: a machine learning model for prediction of response to corticosteroid therapy in COVID-19 patients
    Gao, Yue
    Xiong, Xiaoming
    Jiao, Xiaofei
    Yu, Yang
    Chi, Jianhua
    Zhang, Wei
    Chen, Lingxi
    Li, Shuaicheng
    Gao, Qinglei
    AGING-US, 2022, 14 (01): : 54 - 72
  • [43] Corticosteroid Therapy in Management of Myocarditis Associated with COVID-19; a Systematic Review of Current Evidence
    Kamarullah, William
    Nurcahyani
    Josephine, Claudia Mary
    Multazam, Rachmatu Bill
    Nawing, Aqila Ghaezany
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2021, 9 (01) : 1 - 8
  • [44] PROLONGED CORTICOSTEROID THERAPY AND LUNG ABNORMALITIES IN PATIENTS AFTER SEVERE COVID-19 PNEUMONIA
    Posavec, Anja Ljilja
    Kucic, Daria Cvetkovic
    Zagorec, Nikola
    Malnar, Linda
    Lalic, Kristina
    Zelenika, Marina
    Kovacevic, Ivona
    Kuster, Dinka
    Mutvar, Andreja
    Zivkovic, Nevenka Piska
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (04)
  • [45] Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
    Xiong, Bin
    He, Li-Min
    Qin, Yuan-Yuan
    Du, Hu
    Zhan, Zhu
    Zhou, Yi-Hong
    Chen, Yao-Kai
    Zhang, An
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (15) : 3546 - 3558
  • [46] Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
    Luis M. Pérez-Belmonte
    Jaime Sanz-Cánovas
    Alejandro Salinas
    Iñigo Sagastagoitia Fornie
    Manuel Méndez-Bailón
    Ricardo Gómez-Huelgas
    Internal and Emergency Medicine, 2021, 16 : 2301 - 2305
  • [47] Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study
    Bin Xiong
    Li-Min He
    Yuan-Yuan Qin
    Hu Du
    Zhu Zhan
    Yi-Hong Zhou
    Yao-Kai Chen
    An Zhang
    World Journal of Clinical Cases, 2021, 9 (15) : 3546 - 3558
  • [48] Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy
    Crisan-Dabija, Radu
    Burlacu, Alexandru
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [49] Maternal COVID-19 Disease and COVID-19 Immunization
    Sunder, Amala
    Varghese, Bessy
    Taha, Omer
    Keshta, Mohamed S.
    Bughamar, Ameena Khalid
    Mohamed, Enas Nadir Abelhamid
    Fadhulalla, Yusra Mirghani Aljailani
    Darwish, Basma
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [50] CORTICOSTEROID USE IN SEVERELY HYPOXEMIC COVID-19 PATIENTS
    Rahman, Omar
    Trigonis, Russell
    Craft, Mitchell
    Kruer, Rachel
    Miller, Emily
    Terry, Colin
    Persaud, Sarah
    Kapoor, Rajat
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 124 - 124